Pandemics and Alertness Core Group leader and co-leader of WG1 (Understanding the virus), WG (Fighting the virus) and WG3 (Complementary and enabling techniques), LINXS Fellow

Lund Protein Production Platform (LP3) & Protein Production Sweden (PPS), Department of Biology, Lund University, Lund Sweden

Wolfgang Knecht was trained in human biology at the Philipps-Universität Marburg, Germany, with focus on biochemistry, molecular biology, and virology, followed by a post-doc period at the Technical University of Denmark. Since 2002, he has worked in the cardiovascular research area of AstraZeneca in Mölndal, Sweden, as associate principal scientist in protein production, protein science & enzymology and project leader in early drug discovery projects. In 2013, he joined Lund University (LU) as senior lecturer and director of LP3. LP3 is a university platform for protein production, protein characterization and structure determination. Today, he also serves as the deputy director of the distributed national research infrastructure PPS (Protein Production Sweden), of which LP3 is the LU node. His research is centered around integrated biochemical - structural biology approaches to study enzymes, as lately exemplified by studies of human dihydroorotate dehydrogenase and the complex of the non-structural proteins 10 and 14 of SARS-CoV-2. Since 2025 he has been a SciLifeLab group leader.